Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy.
about
Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Magnetic Resonance Imaging (MR ...... umab and/or Cisplatin Therapy.
@ast
Magnetic Resonance Imaging (MR ...... umab and/or Cisplatin Therapy.
@en
type
label
Magnetic Resonance Imaging (MR ...... umab and/or Cisplatin Therapy.
@ast
Magnetic Resonance Imaging (MR ...... umab and/or Cisplatin Therapy.
@en
prefLabel
Magnetic Resonance Imaging (MR ...... umab and/or Cisplatin Therapy.
@ast
Magnetic Resonance Imaging (MR ...... umab and/or Cisplatin Therapy.
@en
P2093
P2860
P50
P1476
Magnetic Resonance Imaging (MR ...... zumab and/or Cisplatin Therapy
@en
P2093
Amanda Weeks
Connie Yip
David B Landau
Karen Shaw
Musib Siddique
P2860
P304
P356
10.1016/J.TRANON.2017.03.006
P577
2017-04-26T00:00:00Z